Scarica l'app Stockscreener
30.20
3.35%
0.98
Pre-mercato:
29.90
-0.30
-0.99%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$29.22
Aprire:
$29.36
Volume 24 ore:
100.85K
Relative Volume:
0.27
Capitalizzazione di mercato:
$359.55M
Reddito:
$47.11M
Utile/perdita netta:
$15.64M
Rapporto P/E:
40.51
EPS:
0.7455
Flusso di cassa netto:
$-15.89M
1 W Prestazione:
+10.42%
1M Prestazione:
+12.94%
6M Prestazione:
-15.43%
1 anno Prestazione:
+45.61%
Intervallo 1D:
$29.36
$30.95
Intervallo di 1 settimana:
$27.58
$30.95
Portata 52W:
$18.35
$39.92
Xoma Royalty Corp Stock (XOMA) Company Profile
Nome
Xoma Royalty Corp
Settore
Industria
Telefono
510-204-7239
Indirizzo
2200 POWELL STREET, EMERYVILLE, CA
Compare XOMA vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
30.20 | 347.88M | 47.11M | 15.64M | -15.89M | 0.7455 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-17 | Iniziato | The Benchmark Company | Buy |
| 2024-04-29 | Iniziato | Leerink Partners | Outperform |
| 2021-09-07 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-06-29 | Iniziato | Aegis Capital | Buy |
| 2021-01-19 | Reiterato | H.C. Wainwright | Buy |
| 2018-01-18 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-17 | Ripresa | H.C. Wainwright | Buy |
| 2017-09-05 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2017-06-12 | Iniziato | H.C. Wainwright | Buy |
| 2016-11-14 | Downgrade | Wedbush | Outperform → Neutral |
| 2016-03-11 | Reiterato | Wedbush | Outperform |
| 2015-07-23 | Downgrade | Jefferies | Buy → Hold |
| 2015-07-22 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2015-07-22 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2014-10-10 | Ripresa | ROTH Capital | Buy |
| 2014-04-29 | Aggiornamento | MLV & Co | Hold → Buy |
| 2014-03-11 | Downgrade | MLV & Co | Buy → Hold |
| 2014-03-05 | Reiterato | Ladenburg Thalmann | Buy |
| 2013-10-31 | Reiterato | MLV & Co | Buy |
| 2013-05-09 | Reiterato | Ladenburg Thalmann | Buy |
| 2012-05-14 | Iniziato | Cowen & Co | Outperform |
| 2011-03-31 | Reiterato | MLV Capital | Buy |
| 2011-03-23 | Reiterato | RBC Capital Mkts | Outperform |
| 2011-01-06 | Reiterato | Ladenburg Thalmann | Buy |
| 2011-01-04 | Reiterato | Wedbush | Outperform |
Mostra tutto
Xoma Royalty Corp Borsa (XOMA) Ultime notizie
Bear Alert: What drives XOMA Royalty Corporations stock priceWeekly Profit Analysis & Technical Pattern Based Buy Signals - baoquankhu1.vn
XOMA Corp8.375% DP PFD B declares $0.5234 dividend - MSN
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
XOMA shares climb after Q4 results top forecasts on strong royalty income - MSN
XOMA Royalty's (XOMA) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
XOMA Royalty (NASDAQ:XOMA) Issues Quarterly Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat
XOMA Q1 2026 slides: royalty receipts surge 68%, portfolio tops 120 assets - Investing.com Australia
XOMA Royalty Corp 2025 Annual Report: Financials, Nasdaq Listings, and Key Agreements (10-K Filing) - Minichart
XOMA Royalty Q4 Earnings Call Highlights - MarketBeat
XOMA Royalty Declares Quarterly Preferred Stock Dividends - The Manila Times
XOMA Royalty Corporation (XOMA) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
Xoma Royalty 2025 10-K: $52.1M Revenue, $31.7M Net Income - TradingView
XOMA Royalty (NASDAQ: XOMA) grows 2025 royalty cash flow and expands deals - Stock Titan
XOMA Royalty Reports Strong 2025 Financial Results, Expands Portfolio and Anticipates Key 2026 Pipeline Events - Minichart
Earnings call transcript: XOMA Q4 2025 earnings beat boosts stock By Investing.com - Investing.com Canada
Earnings call transcript: XOMA Q4 2025 earnings beat boosts stock - Investing.com
XOMA Royalty Jumps After Q4 Double Beat, Signals Pipeline Catalysts Ahead - Benzinga
XOMA shares jump 7% as strong royalty receipts drive Q4 earnings, revenue beat By Investing.com - Investing.com South Africa
XOMA shares jump 7% as strong royalty receipts drive Q4 earnings, revenue beat - Investing.com
XOMA Royalty (NASDAQ: XOMA) swings to 2025 profit as royalties and milestones surge - Stock Titan
XOMA Royalty Corporation Reports Strong Financial Results and Strategic Developments for Full Year 2025 - Quiver Quantitative
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements - Stock Titan
XOMA Royalty Q4 2025 Earnings Call Transcript - MarketBeat
XOMA (XOMA) CEO granted 126,813 performance units and new RSUs - Stock Titan
XOMA (XOMA) CIO receives stock, PSU grants and updates holdings - Stock Titan
CFO at XOMA (XOMA) receives 138,462 PSUs and 90,000 RSUs - Stock Titan
Equity awards for XOMA (XOMA) Chief Legal Officer include RSUs and PSUs - Stock Titan
Aug Retail: Why is XOMA Royalty Corporation stock going downQuarterly Market Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
XOMA Royalty Corporation EFFE Depositary Shares Representing 1/1000th Perpetual Preferred Stock (XOMAO.US) will release its earnings report before the market opens on March 18. - 富途牛牛
FMR LLC's Strategic Acquisition of XOMA Royalty Corp Shares - GuruFocus
XOMA Royalty (NASDAQ:XOMA) Downgraded to Strong Sell Rating by Zacks Research - MarketBeat
XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 - The Manila Times
XOMA Royalty sets March 18 webcast on 2025 financial results - Stock Titan
XOMA Royalty (XOMA) to Release Earnings on Monday - MarketBeat
XOMA|XOMA Royalty Corp|Price:25.980|Chg%:-0.33 - TradingKey
FMR LLC holds 10.2% of XOMA Royalty (XOMA) after Schedule 13G/A amendment - Stock Titan
Layoff Watch: Why is XOMA Royalty Corporation stock going downJuly 2025 WrapUp & Precise Swing Trade Alerts - baoquankhu1.vn
XOMA Royalty Corporation (NASDAQ:XOMA) Short Interest Update - MarketBeat
XOMA (NASDAQ: XOMA) details 2025 royalty cash, buybacks and litigation costs - Stock Titan
LVTX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
XOMA Royalty Corporation (NASDAQ:XOMA) Receives $60.60 Average Price Target from Brokerages - Defense World
What Analysts Are Saying About XOMA Royalty Stock - Sahm
Leerink raises Xoma stock price target on royalty outlook - Investing.com
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
MURAMural Oncology PLC Latest Stock News & Market Updates - Stock Titan
XOMA Royalty to Present at Investor Conferences in March - 富途牛牛
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right - Intellectia AI
Biotech royalty player XOMA lines up March investor talks - Stock Titan
Short Interest in XOMA Royalty Corporation (NASDAQ:XOMA) Grows By 27.4% - MarketBeat
What drives XOMA Royalty Corporation’s stock priceJuly 2025 Gainers & Smart Swing Trading Alerts - mfd.ru
XOMA Royalty (NASDAQ:XOMA) Upgraded by TD Cowen to "Hold" Rating - MarketBeat
Xoma Royalty Corp Azioni (XOMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):